Search results
Psoriasis pain: Prevalence and how to manage it
Medical News Today· 7 days agoPeople may describe psoriasis pain as itchy, achy, or stinging, with the feeling varying from person to person. Strategies such as using distraction,...
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
Digital Journal· 11 hours agoEntered into a worldwide license and collaboration agreement for rusfertide with Takeda; Cash runway extended through Q4 2027[1]Enrollment in both Phase 3 ICONIC LEAD and ICONIC TOTAL trials ...
Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
GuruFocus.com via Yahoo Finance· 7 hours agoThe company has successfully completed enrollment for the Phase 3 trials of JNJ-2113 for treating...
VYNE Therapeutics receives FDA approval for trial of VYN202
Clinical Trials Arena via Yahoo Finance· 21 hours agoThe company expects to report top-line results from the SAD/MAD trial in...oral bioavailability....
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 7 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent of people with ...
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
InvestorPlace· 14 hours agoInvestors concerned about broader market undulations may want to consider the resilience narrative...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 6 days agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
Why Does It Burn When I Pee After Sex? Potential Causes and Solutions
Verywell Health via Yahoo News· 2 days agoA burning sensation when peeing after sex is medically called dysuria, and it can have many causes...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 5 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 6 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.